Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.32 |
| ▸ | MAOB | P27338 | 1/20 | 0.31 |
| ▸ | PLA2G2A | P14555 | 2/20 | 0.31 |
| ▸ | PLA2G4A | P47712 | 2/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19157030 | 0.92 | ALOX5 (0.32) | ALOX5 | |
| SCHEMBL18101521 | 0.92 | ALOX5 (0.32) | ALOX5MAOBPLA2G2APLA2G4AL3MBTL1 | |
| SCHEMBL19156865 | 0.91 | ALOX5 (0.34) | ALOX5MAOBPLA2G2APLA2G4A | |
| SCHEMBL18101544 | 0.91 | TNKS (0.32) | ALOX5 | |
| SCHEMBL18101588 | 0.91 | ALDH1A1 (0.32) | ALOX5 | |
| SCHEMBL18101522 | 0.90 | CYP1A2 (0.31) | ALOX5MAOBGAA | |
| SCHEMBL18101506 | 0.89 | ALOX5 (0.34) | ALOX5MAOBPLA2G2APLA2G4A | |
| SCHEMBL18101519 | 0.89 | ALOX5 (0.34) | ALOX5MAOBPLA2G2APLA2G4AL3MBTL1 | |
| SCHEMBL18101516 | 0.88 | HPGD (0.33) | ALOX5GAA | |
| SCHEMBL18101524 | 0.88 | KDM4E (0.35) | ALOX5MAOBL3MBTL1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3196198-A1 | NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING SAME | Idemitsu Kosan Co., Ltd (JP) | 2017-07-26 | — | — | EP | disclosed |
| US-20160284998-A1 | NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE OBTAINED BY USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2016-09-29 | — | — | US | disclosed |
| US-20160284998-A1 | NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE OBTAINED BY USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2016-09-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160284998-A1 | NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE OBTAINED BY USING SAME | EPB41, RPS4X, OR10J3 | ALOX5 2749/4885MAOB 2554/4885PLA2G2A 4479/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.